asn.dev

Autonomous system

AS3902 GLAXOSMITHKLINE

Unclassified ARIN

IPv4 addresses 1.02K 4 prefixes
IPv6 prefixes 0 counted as prefixes, not addresses
Countries 1 mostly US
Exchanges 0 recorded by PCH
Upstreams 1 0 downstream
Flagged prefixes 0 none

Summary

GlaxoSmithKline (GSK)

United States · AI-generated

enterprise legacy

Corporate network of GlaxoSmithKline (GLAXOSMITHKLINE), the global pharmaceutical company, registered through ARIN at its US offices in Philadelphia, Pennsylvania.

What it's used for

  • Enterprise networking for GSK's own sites — offices, research facilities, and internal systems.
  • About 1,000 IPv4 addresses, an enterprise-sized footprint rather than a provider one.

Notable

  • This is a corporate network: traffic from this range is a pharmaceutical company's employees and infrastructure, not consumers.
  • The ASN was registered with ARIN in 1994, under a name that only came into existence in 2000 when Glaxo Wellcome merged with SmithKline Beecham — the registry record was clearly renamed as the corporate identity changed beneath it.

This description is AI-generated, best-effort context — not authoritative, and provided without any guarantee of accuracy. Source, and how to suggest an edit.

Interconnection

Peering at a glance

Full topology · Graph

Internet exchanges

No exchange port on file. Many exchanges publish no participant list, so this is not proof of absence.

Transit providers

1 upstream, 0 downstream and 1 adjacent networks observed; most-used upstreams first.

ASNetworkPaths seen
AS10753Level 3 Parent, LLC240

Exchange presence is recorded rather than inferred: the directory collected by Packet Clearing House (https://www.pch.net/ixp/data) on 2026-10-26, licensed CC BY-NC-SA 3.0. Transit is inferred from observed BGP paths, never declared by either party.

Address space

Summary

Shape and geography

IPv4 4 prefixes · 1.02K addresses IPv6 0 prefixes

CountryNamePrefixes
USUnited States of America4

Registry

Allocation record

ARIN · via Atlas (registry + RDAP)
Registry
ARIN
Handle
AS3902
Registry name
GLAXOSMITHKLINE
Registrant
GlaxoSmithKline
Abuse contact
csir@gsk.com
Registered
1994-10-04
Last changed
2007-06-08
Allocation
assigned

Routing security

RPKI and IRR

Full detail
RPKI
0% valid · 0 valid, 4 with no ROA
ROAs
0 authorising AS3902
ASPA
no ASPA record
IRR
75% registered · 3 of 4 announcements
Route objects
3 naming AS3902

Reputation

Classification and threat

Unclassified Not in the curated lists. Most of the ~80,000 allocated ASNs are not.

Spamhaus DROP

Not on ASN-DROP The network as a whole is not listed.

No DROP prefixes None of its announced space is on the DROP prefix list.

Spamhaus DROP ("Don't Route Or Peer") lists space and networks run by, or hijacked for, spam and cybercrime operations: 446 networks and 1,852 prefixes, as published 2026-10-27. A short, high-confidence list, so a match is worth taking seriously, and absence from it says little on its own.

FBI IC3

No IC3 indicators Nothing from the FBI IC3 feed.

IC3 threat data is alpha. Absence of an indicator is not evidence of good behaviour, only of absence from this one feed.

Elsewhere

Cross-check